baber/WOPTO huggingface dataset:
Patent AU-572817-B2 (AU)
Title: Spring mount hinge for eyeglasses legs
Inventor: SARTOR RINO
IPC: G02C5/22
Filed: 1984-02-01
Granted: 1988-05-19
Abstract: The invention is concerned with an eyeglasses leg mount on which spring-loaded devices are active enabling the leg opening to occur elastically beyond an overcenter position, and enabling the leg (1) to be closed with a snap action, the spring-loaded devices comprising a leaf spring (17) pivotally inserted into a pocket (2) formed in the eyeglasses leg (1)and acting with its free end onto a mushroom head (8) made rigid with the eyeglasses frame (10), and shaped to provide two stable opened-closed positions for the leg (1), resilient extra opened positions and an opening travel limit stop therefor.
Patent AU-577038-B2 (AU)
Title: A panel assembly
Inventor: MUNN JOHN BARRIE
IPC: E04C2/34
Filed: 1984-01-05
Granted: 1988-09-15
Abstract: A panel assembly for use in constructing flooring walls or ceiling has two panels (1,2) each having a planar surface (3,4) on one side and on its opposite side (5,6) a plurality of bosses (7,8) projecting from the panel. The panels (1,2) are interconnected by abuttment of the bosses (7) of one panel (1) with the bosses (8) of the other panel (2) and a locking member (12,18) is associated with some of the abutting bosses to thereby prevent lateral movement of panel (1) relative to the other panel (2). The locking members (18) may be tubular and/or comprise locking pins (12) arranged to pass through bores in some abutting bosses. When used as a flooring the panel assembly is installed on a concrete base (26) having a substantially flat surface and bedded on an adhesive compound (25). A number of panel assemblies will be required to construct the flooring wall or ceiling, but once constructed a number of individual panels may be removed to readily allow the installation of mains services.
Patent AU-644545-B2 (AU)
Title: Method for treating hypertension
Inventor: LARSON ERIC ROBERT
IPC: A61P9/12
Filed: 1992-09-23
Granted: 1993-12-09
Abstract: The use of a compound of formula (I): <CHEM> wherein X is C=0 or CHOH, or a pharmaceutically acceptable salt thereof, for the manufacture of medicaments for treating hypertension.
Patent AU-750124-B2 (AU)
Title: A tool ring and a nail machine comprising such tool ring
Inventor: JENSEN JORN BOIE
IPC: B21G3/32
Filed: 1999-03-31
Granted: 2002-07-11
Abstract: A nail machine and a tool ring for securing elongate bodies in the manufacture of heads on the elongate bodies. The tool ring has an axis of rotation, an outer circumference and a surface that extends substantially perpendicular to the axis fo rotation, and wherein the tool ring comprises a number of engagement devices spaced substantially equally at the circumference of the tool ring for receiving and releasably securing the elongate bodies. Each of the engagement devices has two mutually opposed holding jaws, at least one of which is movable and arranged on a movement mechanism so that it can be displaced towards and away from the opposed holding jaw. The engagement devices also have two opposed holding trays which are movable towards one another. The movement mechanism is arranged so that it displaces the movable holding jaw in a radial or axial direction relative to the axis of rotation of the tool ring to engage and position the elongate body and then clamp the elongate body by the holding trays with greater force to hold the elongate body securely while the head is formed thereon.
Patent AU-754380-B2 (AU)
Title: Method of preventing the death of retinal neurons and treating ocular diseases
Inventor: KLJAVIN IVAR J
IPC: A61K38/00
Filed: 1999-03-10
Granted: 2002-11-14
Abstract: The present invention relates to the use of FGF-5 polypeptides to delay, prevent or rescue retinal neurons, including photoreceptors, other retinal cells or supportive cells (e.g. Müller cells or RPE cells) from injury and degradation. Conditions comprehended by treatment of the present FGF-5 polypeptides (including variants), antibodies, compositions and articles of manufacture include: retinal detachment, age-related and other maculopathies, photic retinopathies, surgery-induced retinopathies (either mechanicallyy or light-induced), toxic retinopathies including those resulting from foreign bodies in the eye, diabetic retinopathies, retinopathy of prematurity, viral retinopathies such as CMV or HIV retinopathy related to AIDS, uveities, ischemic retinopathies due to venous or arterial occlusion or other vascular disorder, retinopathies due to trauma or penetrating lesions of the eye, peripheral vitreoretinopathy, and inherited retinal degenerations. Exemplary retinal degenerations include e.g., hereditary spastic paraplegia with retinal degeneration (Kjellin and Barnard-Scholz syndromes), retinis pigmentosa, Stargardt disease, Usher syndrome (retinits pigmentosa with congenital hearing loss), and Refsum syndrome (retinitis pigmentosa, hereditary hearing loss, and polyneuropathy). Additional disorders which result in death of retinal neurons include, retinal tears, detachment of the retina and pigment epithelium, degenerative myopia, acute retinal necrosis syndrome (ARN), traumatic chorioretinopathies or contusion (Purtscher's Retinopathy) and edema.
Patent AU-577535-B2 (AU)
Title: Coupling device with hinged retaining catches
Inventor: ZAMORA PEDRO CUERDA
IPC: F16L15/00
Filed: 1984-07-23
Granted: 1988-09-29
Abstract: Coupling device with hinged retaining catches made up basically of two concentric cylindrical parts (1, 9), the inner one of which extends frontally by means of clamping catches (2) provided on their inner face with retention toothing (3), these catches (2) being joined to the cylindrical body (1) of which they form a part, by hinges (4) which are integrated through the thinning of the actual material of which they are made, thereby offering said catches (2) the possibility of swivelling although with a constant tendency to separate in relation to the longitudinal axis of the cylindrical body of which they form a part.
Patent AU-773349-B2 (AU)
Title: Improvements in and relating to training ammunition
Inventor: SAXBY MICHAEL ERNEST
IPC: F41A33/00
Filed: 2001-02-08
Granted: 2004-05-20
Abstract: The invention provides a training cartridge having a peripheral fire primer and a gun modified to fire the cartridge. The combination of modified gun and peripheral fire cartridge avoids the potentially adverse consequences that could arise if live ammunition and training ammunition were to become inadvertently confused or mixed up by preventing the firing of live center fire ammunition.
Patent AU-572543-B2 (AU)
Title: Silanes or organosiloxanes
Inventor: HILL MICHAEL PHILIP LOUIS
IPC: C07F7/08
Filed: 1984-08-17
Granted: 1988-05-12
Abstract: Organosilicon compounds which are silanes or siloxanes characterized by the presence of silicon-bonded groups represented by the general formula  <IMAGE>  in which R' is a divalent hydrocarbon group which may contain ether oxygen, R'' represents -CHBCH2- or -C6H9B- in which B is OH or the group  <IMAGE>  a and n are each 0 or 1 and Y is -OH, lower alkoxy or -NX2 wherein X represents hydrogen or lower alkyl. The compounds are prepared by the reaction of an organosilicon compound having an organic substituent which contains an epoxy group, and the appropriate acid or acid chloride. They absorb ultra violet radiation and are useful as cosmetic and other sunscreen agents.
Patent AU-621870-B2 (AU)
Title: Dilatation catheter with a microporous permeable balloon
Inventor: SCHNEIDER ERNST
IPC: A61F2/958
Filed: 1989-04-19
Granted: 1992-03-26
Abstract: Arranged on a support tube (3) is a collapsible dilatation balloon (1), which can be brought, for example, with the aid of a guide wire (2), to a stricture in a vessel to be widened. In order to dilate the collapsed balloon (1), the latter is filled under pressure with a fluid (13) via a channel (4) in the support tube (3). The balloon (1) has a microporous wall (5) which is permeable to the fluid. Upon treatment of a stenosis, stricture tissue is mechanically displaced and, at the same time as the fluid (13), a treatment agent, in particular a substance dissolving the stricture tissue, is introduced directly into the stricture tissue. 
<IMAGE>
Patent AU-659538-B2 (AU)
Title: Container closure with frangible bridges
Inventor: THOMPSON NIGEL
IPC: B65D41/34
Filed: 1993-03-12
Granted: 1995-05-18
Abstract: The invention provides container closure moulded from a plastics material and comprising a crown (1), an annular skirt (2) depending from the crown and provided with a screw-thread (3) on its internal surface, a tamper-evident ring (4) connected to the free end of the annular skirt by series of frangible bridges (6) extending across an axial gap or circumferential line of weakening (5) between the ring and the skirt, said ring having on its inner surface a series of integral radially inwardly projecting protrusions (7) each having a contact surface (8) generally facing the crown, wherein each bridge is formed with a weakened portion (17) in the unscrewing direction, whereby during unscrewing of the closure fronm a container neck with a security band formation, the fracture of the bridges occurs as a resultant of tension and shear forces to give a sequential separation. <IMAGE>
Patent AU-780377-B2 (AU)
Title: Purified LH
Inventor: PARADISI GIANFRANCO
IPC: C07K1/36
Filed: 2001-01-22
Granted: 2005-03-17
Abstract: A process for the purification of recombinant human Luteinizing Hormone (LH) from a sample of crude recombinant LH in the supernatant of CHO cells comprises the combined use of ion-exchange chromatography and reverse phase HPLC. The ion-exchange chromatography and the reverse phase HPLC are performed twice and the final use of a gel permeation column allows the purification from any residual traces of contaminants. The specific bioactivity of the highly purified LH obtained from the process is particularly high, amounting to about 25.000 IU/mg.
Patent AU-632969-B2 (AU)
Title: Sprinkler head having protuberant ridge valve seat
IPC: A62C37/12
Filed: 1989-06-19
Granted: 1993-01-14
Abstract: The invention relates to a fire protection sprinkler head having a base (12) constructed for connection to a source of fire retardant fluid under pressure, a throat (14) in the base through which fire retardant fluid can flow, a valve seat (16) defined by the base about the periphery of the throat, and a resiliently flexible valve disk (18) disposed across the throat and impressed upon the valve seat in sealing engagement. The valve seat has an arcuate profile segment, with a protuberant ridge (44) disposed about the periphery of the throat and adjacent thereto. The ridge, in the region of its crest (45), defines a valve seat surface (46). The valve seat further has a recessed surface segment (48) disposed radially outwardly of the throat, and divergent from the a plane of the crest of the protuberant ridge. The valve disk has a sealing surface (47) which is impressed upon the valve seat surface (46) in the region of the crest of the protuberant ridge in sealing engagement over an annular region inward of the peripheral edge (51) of the valve disk and in a manner to minimize the radial width of the valve seat surface, to thereby improve valve seat performance in resistance to leakage.
Patent AU-628845-B2 (AU)
Title: Vaccine
Inventor: HOWARD JOHN CHRISTOPHER
IPC: C12N7/04
Filed: 1989-08-03
Granted: 1992-09-24
Abstract: A vaccine comprises a non-cytopathogenic strain of bovine viral diarrhoea virus, grown in a bovine derived cell line such as MDBK and killed, for example with  beta -propiolactone. The adjuvant is Quil A.
Patent AU-703580-B2 (AU)
Title: Desensitizing teeth with degradable particles
Inventor: MASTERMAN THOMAS CRAIG
IPC: A61K8/04
Filed: 1995-11-09
Granted: 1999-03-25
Abstract: A method for desensitizing a hypersensitive tooth in a patient includes contacting exposed tubules with particles including a degradable material.
Patent AU-637955-B2 (AU)
Title: Credit card counter with phase error detecting and precount comparing verification system
IPC: G06M3/02
Filed: 1989-08-17
Granted: 1993-06-10
Abstract: A card counter (10) prints card inventory information locally and communicates with a remote computer (43) for permanent storage and retrieval of inventory information. A microprocessor controller detects a counting error in response to the actual count failing to match a preset count, failing to match a precount information machine read from a machine readable precount label (130) attached to the cards (18), in the event of a phase error from a pair of parallel scanning card sensor circuits (58, 59) or if the final counts of the two card sensor circuits (58, 59) do not match. In the event of detection of a counting error, an error indication is provided and entry of the count into an accumulator memory is inhibited. The preset number is entered into memory by selectively entering an actual count into the preset memory. A pair of separate accumulators are provided for concurrently accumulating totals of two different groups of cards (18). The card sensor circuits (58, 59) are digitally filtered by the microprocessor (44) which also automatically performs self diagnostics to reduce countin errors due to malfunction. Malfunction of a scan drive motor (61) is reduced through provision of a slip clutch (Figs. 10A and 10B). Alphanumeric display units are both electrically connected to the control circuit (Fig. 2) and releasibly, mechanically attached to a printed circuit board (112) of said control circuit (Fig. 2) by means of a multiline electrical connector (120) attached to the edge of the printed circuit board (112).
Patent AU-717683-B2 (AU)
Title: Nutritional formula for phenylketonuria patients
Inventor: MASSON GERARD
IPC: A23L33/19
Filed: 1997-08-25
Granted: 2000-03-30
Abstract: A nutritional formula for PKU patients. The nutritional formula has, as a protein source, a mixture of caseino-glyco-macropeptide and complementary essential amino acids other than Phe to provide a balanced amino acid profile. Vitamins and minerals sufficient to meet daily requirements are also included. When used as a complete diet, the nutritional formula includes a carbohydrate source and a fat source. However the nutrutional formula may also be used as a protein supplement in which case the carbohydrate source and the fat source may be omitted. The nutritional formula has a pleasant taste.
Patent AU-710231-B2 (AU)
Title: Fischer-tropsch catalyst and process for preparing hydrocarbons
Inventor: BLANKENSTEIN PAUL
IPC: C07C9/14
Filed: 1997-09-09
Granted: 1999-09-16
Abstract: The present invention relates to a Fisher-Tropsch catalyst comprising a compound of a catalytically active metal supported on a titania catalyst carrier having a rutile:anatase ratio of less than 2:3, and a surface area of less than 75 m<2>/g. The invention further relates to a process for the preparation of such catalyst, and to a process for the preparation of hydrocarbons which comprises contacting a mixture of hydrogen and carbon monoxide at elevated temperature and pressure with the said catalyst.
Patent AU-727174-B2 (AU)
Title: Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity
Inventor: CILIBERTO GENNARO
IPC: A61K48/00
Filed: 1997-11-18
Granted: 2000-12-07
Abstract: The present invention relates to methods for screening for anti-obesity agents using the ciliary neutrophic factor receptor.
Patent AU-763834-B2 (AU)
Title: Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz(F)indoles, method for the production thereof, and their use as medicaments
Inventor: GRAUERT MATTHIAS
IPC: A61P25/28
Filed: 1999-07-22
Granted: 2003-07-31
Abstract: The present invention relates to new substituted 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indole derivatives, processes for preparing them and their use as pharmaceutical compositions. The indole derivatives according to the invention correspond to general formula 1:
Patent AU-763106-B2 (AU)
Title: Wavelength-shifting probes and primers
Inventor: TYAGI SANJAY
IPC: C12Q1/6818
Filed: 1999-07-28
Granted: 2003-07-10
Abstract: Hairpin-forming oligonucleotide probes and primers triple-labeled with a pair of florophores, a shorter wavelength harvester and a longer wavelength emitter, and a quencher. When the probes and primers are stimulated by light that excites the harvester, opening causes an increase in fluorescence by the emitter, while fluorescence from the harvester is continually suppressed. The probes and primers may be used for detection of nucleic acid targets in assays, including amplification assays. Assay kits are provided.
Patent AU-696979-B2 (AU)
Title: Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
Inventor: WILSON JAMES M
IPC: A61K38/17
Filed: 1996-02-23
Granted: 1998-09-24
Abstract: The invention provides a recombinant viral vector comprising the DNA of, or corresponding to, at least a portion of the genome of an adenovirus, which portion is capable of infecting a hepatic cell; and a human VLDL receptor gene operatively linked to regulatory sequences directing its expression. The vector is capable of expressing the normal VLDL receptor gene product in hepatic cells in vivo or in vitro. This viral vector is useful in the treatment of metabolic disorders caused by the accumulation of LDL in plasma, such as familial hypercholesterolemia or familial combined hyperlipidemia.
Patent AU-730195-B2 (AU)
Title: Power transformer/inductor
Inventor: FROMM UDO
IPC: H01F27/28
Filed: 1998-02-02
Granted: 2001-03-01
Abstract: A power transformer/inductor includes at least one winding. The winding is made of a high voltage cable that includes an electric conductor, and around the electric conductor is arranged a first semiconducting layer, around the first semiconducting layer is an insulating layer, and around the insulating layer is a second semiconducting layer. The second semiconducting layer is directly earthed at both ends of the winding and furthermore at least at two points per turn of every winding such that one or more points are indirectly earthed.
Patent AU-693370-B2 (AU)
Title: Float with automatic triggering device
Inventor: MARIC MIJO
IPC: A01K93/00
Filed: 1996-06-11
Granted: 1998-06-25
Abstract: PCT No. PCT/DE96/01015 Sec. 371 Date Mar. 2, 1998 Sec. 102(e) Date Mar. 2, 1998 PCT Filed Jun. 11, 1996 PCT Pub. No. WO97/00009 PCT Pub. Date Jan. 3, 1997A float (10) having an automatic triggering device for a fishing apparatus includes an inner sleeve (13) which can be inserted into a float housing (11) in a direction of the longitudinal axis of the float housing (11) in opposition to the force of tensioning spring (14) and is held by means of a spring catch (15) in the inserted state. The spring catch (15) can be locked in this position by means of a contact lever (21). The locking can be released through deflection of the contact lever (21) in the direction of the longitudinal axis of the float housing (11). A fishing line (23) is passed through the inner sleeve (13) and is connected to a driver element (25, 26), disposed above the inner sleeve (13) in such a fashion that the inner sleeve (13), during motion out of the inserted locked state into the initial state, pulls along, with the assistance of the driver element (25, 26), the fishing line (23) as well as a fishing hook (28) connected to the fishing line (23). The spring catch (15) and the contact lever (21) have oppositely lying rotational axes (20, 22) mounted on the float housing (11). One end of the contact lever (21) seats on an inner side of the spring catch (15) to lock the spring catch (15) in the inserted state of the inner sleeve (13). The fishing line (23) has an enlargement (24) which presses directly on and deflects the contact lever (21) when the fishing hook (28) is pulled. In this manner, the automatic triggering device of the float is protected against unintentional triggering during casting and in the event of large surface waves while exhibiting a rapid and sensitive response.
Patent AU-581091-B2 (AU)
Title: Polyvinyl butyral sheet roughness control
Inventor: CARTIER GEORGE ETIENNE
IPC: C08F8/28
Filed: 1986-07-01
Granted: 1989-02-09
Abstract: Extruded polyvinyl butyral (PVB) sheet roughness is controlled by use of PVB resin lightly cross-linked through stable intermolecular linkages.
Patent AU-652721-B2 (AU)
Title: Pressure transmitter with flame isolating plug
Inventor: WALISH JAMES E
IPC: G01L9/04
Filed: 1990-07-31
Granted: 1994-09-08
Abstract: A transmitter that provides an output indicating pressure difference between a line pressure and atmosphere outside the transmitter is made intrinsically safe by coupling the sensor cavity as well as other cavities where ignition can occur to atmosphere only through flame quenching paths. The opening in the transmitter housing in which the sensor is mounted has a plug including a sensor cavity that holds the sensor, and a fitting which is couplable to the pressure line. An isolator is used for transmitting the process pressure to the sensor through an isolator diaphragm acting on an incompressible filling the sensor cavity and transmitting pressure through a hole that is shaped to provide a flame quenching path. The passageway flame isolates the sensor from the process fluid line. The opposite side of the sensor is connected to atmosphere only through paths which are flame quenching because of the passageway shape. The plug is an assembly that can be made easily inserted and removed, and provides intrinsic safety even if there is failure of some of the components such as the isolating diaphragm or welds holding portions of the plug together.
Patent AU-690898-B2 (AU)
Title: Regulated transcription of targeted genes and other biological events
Inventor: CRABTREE GERALD R
IPC: C10G7/06
Filed: 1994-02-14
Granted: 1998-05-07
Abstract: Dimerization and oligomerization of proteins are general biological control mechanisms that contribute to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins. In principle, any two target proteins can be induced to associate by treating the cells or organisms that harbor them with cell permeable, synthetic ligands. To illustrate the practice of this invention, we have induced: (1) the intracellular aggregation of the cytoplasmic tail of the ¶ chain of the T cell receptor (TCR)-CD3 complex thereby leading to signaling and transcription of a reporter gene, (2) the homodimerization of the cytoplasmic tail of the Fas receptor thereby leading to cell-specific apoptosis (programmed cell death) and (3) the heterodimerization of a DNA-binding domain (Gal4) and a transcription-activation domain (VP16) thereby leading to direct transcription of a reporter gene.  Regulated intracellular protein association with our cell permeable, synthetic ligands offers new capabilities in biological research and medicine, in particular, in gene therapy. Using gene transfer techniques to introduce our artificial receptors, one can turn on or off the signaling pathways that lead to the overexpression of therapeutic proteins by administering orally active "dimerizers" or "de-dimerizers", respectively. Since cells from different recipients can be configured to have the pathway overexpress different therapeutic proteins for use in a variety of disorders, the dimerizers have the potential to serve as "universal drugs". They can also be viewed as cell permeable, organic replacements for therapeutic antisense agents or for proteins that would otherwise require intravenous injection or intracellular expression (e.g., the LDL receptor or the CFTR protein).